Marjo E. Van Kasteren

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.

Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.

Journal: Viruses

Published: December 10, 2023

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.

Journal: Open forum infectious diseases

Published: October 19, 2023

A man with cervical lymph node swelling

A man with cervical lymph node swelling

Journal: Nederlands tijdschrift voor geneeskunde

Published: March 15, 2023

Neurosyphilis mimicking giant cell arteritis both clinically and microscopically.

Neurosyphilis mimicking giant cell arteritis both clinically and microscopically.

Journal: BMJ case reports

Published: May 31, 2022

COVID-19: patient zero in the Netherlands

COVID-19: patient zero in the Netherlands

Journal: Nederlands tijdschrift voor geneeskunde

Published: July 03, 2020

Non-typhoidal Salmonellainfections: not always innocent

Non-typhoidal Salmonellainfections: not always innocent

Journal: Nederlands tijdschrift voor geneeskunde

Published: April 24, 2020

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy.

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy.

Journal: EClinicalMedicine

Published: May 19, 2019

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.

Journal: The lancet. Gastroenterology & hepatology

Published: October 12, 2018

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).

8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).

Journal: Journal of hepatology

Published: June 27, 2018

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 28, 2017

The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever.

The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 27, 2017

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

Journal: Frontiers in pharmacology

Published: March 31, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026